Figure 6

Impact of PBX3 expression levels on prognosis. (A) Kaplan-Meier curves of overall survival (OS) in AML with low versus high expression of PBX3 displaying no significant difference between these two groups of AML patients; (B) Cumulative incidence of relapse showing higher relapse rates in PBX3-overexpressing AML patients (P = 0.004).